Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer

Lignende værker

• Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss
  af: Beauchamp, Ellen M., et al.
  Udgivet: (2013)
• NSCLC Driven by DDR2 Mutation is Sensitive to Dasatinib and JQ1 Combination Therapy
  af: Xu, Chunxiao, et al.
  Udgivet: (2015)
• Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma
  af: Liao, Rachel G., et al.
  Udgivet: (2013)
• Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
  af: Kim, Hyung-Gu, et al.
  Udgivet: (2014)
• Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer
  af: Hammerman, Peter S, et al.
  Udgivet: (2011)